相关实验视频
Updated: May 25, 2025

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.1K
喘的表型和生物标志物
Jocelyn R Grunwell1, Anne M Fitzpatrick2
1Dr. Grunwell is affiliated with Division of Critical Care Medicine, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia.
Respiratory care
|February 27, 2025
概括
通过2型高和2型低的炎症表型,更好地了解严重的喘异质性. 生物标志物评估指导了针对成人和儿童重症喘治疗的生物选择.
科学领域:
- 免疫学和肺病学.
- 翻译医学是一种翻译医学.
- 临床的表型化 临床的表型化
背景情况:
- 喘在成人和儿童中呈现不同的表型,严重的病例表现出持续的症状,尽管治疗.
- 研究重点是严重的喘异质性,导致识别2型高和2型低的炎症概况.
- 2型高喘涉及特定的免疫路径和eosinophilic炎症,而2型低喘是不太了解和耐皮质类固醇.
研究的目的:
- 审查成人和儿科喘表型的病理生物学.
- 讨论严重喘的基于表型的治疗策略,包括生物疗法.
- 探索临床表型,以指导门诊管理,并确定潜在的高风险儿科表型.
主要方法:
- 审查有关喘病理生物学,表型和治疗的现有文献.
- 对分类方法的分析,包括监督和无监督方法.
- 对生物标志物面板的评估,以指导严重喘中的生物选择.
主要成果:
- 严重的喘根据炎症标志物被分为2型高和2型低的表型.
- 针对2型高炎症的生物药物在减少恶化方面表现有前途.
- 生物标记面板 (血液中乙氨基基,IgE,FeNO) 有助于选择适当的生物疗法.
结论:
- 了解喘表型对于个性化治疗策略至关重要.
- 生物疗法为严重喘提供了有针对性的选择,特别是2型喘.
- 需要进一步的研究来充分描述2型低喘,并确定高风险的儿科表型,包括需要接受ICU治疗的儿童.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
324
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
324
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
222
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
222

